The research, conducted in collaboration with the University of Copenhagen and Bispebjerg-Frederiksberg Hospital, shows that HERV-K activates when cells face metabolic stress. This reactivation triggers a cascade of pro-inflammatory responses, providing a potential biological link between obesity, insulin resistance, and accelerated aging. Clinical data confirmed these findings by detecting elevated levels of the virus in human plasma samples from volunteers with obesity.
In section Releases
HERV-K Linked to Metabolic Senescence in New Clinical Findings
Ancient viral sequences embedded in the human genome are fueling inflammation in patients living with obesity, according to new research from HERVolution Therapeutics. The findings, presented at the International Congress on Obesity in Mexico City, identify HERV-K reactivation as a primary driver of stress-associated adipocyte inflammation.
J. Robert Coleman, CEO of HERVolution Therapeutics, stated that the data positions HERV-K at the center of the biology connecting chronic inflammation and cellular senescence. The company intends to leverage these results to expand its immunotherapeutic platform, which targets HERV-derived antigens, beyond oncology. Their lead program, IPT-001, is currently moving toward human trials to test whether neutralizing these viral sequences can mitigate disease progression in both metabolic and cancer-related contexts.
Comments (0)
No comments yet. Be the first!